Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Sutro Biopharma (STRO) Long-Term Debt Issuances (2020)

Sutro Biopharma (STRO) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $25.0 million as the latest value for Q1 2020.

  • Quarterly Long-Term Debt Issuances changed N/A to $25.0 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2020, changed N/A year-over-year, with the annual reading at $25.0 million for FY2020, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $25.0 million in Q1 2020 for Sutro Biopharma.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $25.0 million in Q1 2020 to a low of $25.0 million in Q1 2020.